02/20/2025
4:45 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:59 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:33 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:14 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:55 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:55 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:55 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:57 PM | Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CNTA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/04/2025
3:57 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:08 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
3:04 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
3:32 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:07 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
3:16 PM | Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
6:00 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:30 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:31 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:33 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
4:28 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
5:10 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:22 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:18 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
4:09 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:10 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:11 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:02 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:14 PM | Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:03 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:14 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:03 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:07 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
4:06 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:33 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:43 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The real reason gold is soaring (and likely to continue) (Ad) Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit
Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast! Discover Garrett’s highly sought-after gold insights and seize this opportunity before it’s gone. |
11/12/2024
6:16 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
6:19 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:27 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:07 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:15 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/27/2024
3:15 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:01 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:55 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:40 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form S-3ASR | |
09/10/2024
3:04 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:06 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:06 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:12 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:13 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:19 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
4:15 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:32 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:13 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:38 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:52 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
6:27 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:31 PM | Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:31 PM | Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:33 PM | Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:34 PM | Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:34 PM | Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:14 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:49 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/10/2024
6:13 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:48 PM | Centessa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/13/2024
3:32 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:00 AM | Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |
05/09/2024
7:01 AM | Centessa Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
7:53 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/24/2024
8:26 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
4:16 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/22/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:17 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Your Wealth is Under Attack (Ad) Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold. Click here now to see how to stop them in their tracks! |
04/02/2024
3:16 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:44 PM | Centessa Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:16 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:06 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
